Amarin (AMRN) Vascepa NCE Status Not in June FDA Orange Book
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Up)Join SI Premium – FREE
Amarin Corp (Nasdaq: AMRN) Vascepa NCE status not listed in June Orange Book. To view the update, click here.
Shares of Amarin are up 5.8 percent Monday.
Shares of Amarin are up 5.8 percent Monday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acrivon Therapeutics (ACRV) Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
- Nanometrics (NANO) Issues Business Update, Reports FY23 Results
- Ford (F) earnings beat estimates in Q1, revenue falls short; stock up
Create E-mail Alert Related Categories
Corporate News, FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
